FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PROGRAF (tacrolimus) submitted by Astellas Pharma US, Inc. The action relates to an update of the product labeli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation
• Kidney Transplantation
• Liver Transplantation

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

SUPPL AP for PROGRAF (TACROLIMUS)